Anthem Biosciences raises Rs 1,016 crore from anchor investors ahead of IPO
National Anthem Biological Sciences IPO: The Bengaluru-based company, Anthem Biosciences, has received Rs 1,016 crore from Anchor Investors ahead of its upcoming initial public offering (IPO), which opened a public subscription on July 14.
According to the BSE website, the company has allocated 1.78 billion equity shares, each at 60 host investors at Rs 570 per share, which is the upper end of the IPO price band.
List of National Anthem Biological Science Anchor Books
This anchor book attracted the participation of several global and domestic institutional investors. Here is the list:
- Abu Dhabi Investment Bureau
- Government pension funds globally
- EastSpring Investing
- Amundi Funds
- Pinebridge Global Fund
- Sociétégénérale
- HDFC MF
- ICICI Prudential MF
- Axis MF
- UTI MF
- Quantum MF
- Motilal Oswal MF
National Anthem Biosciences IPO: Price band, batch size, key details
This issue is an offer from the company’s salesmen, investors and other personnel materials (OFS). This means that the company will not get any benefits from this question, which will be purely various suggestions. However, information such as batch and price bands has not been disclosed.
Price band, batch size
The company has fixed the price band between Rs 540 and Rs 570 per share. Investors can apply for 26 shares per person, while multiplier can apply.
Financial performance
The company reported revenue in FY25 was Rs 18,44 crore, up 30% year-on-year, compared with Rs 1,419 crore in FY24. During the same period, its after-tax profit (PAT) rose 23% to Rs 45.1 crore.
Listed competitors
The company has several industry peers, some of which are leaders in the field, including SAI Life Sciences Limited, Syngene International, Suven Life Sciences and Divi’s labs.
BRLMS, Registrar details
JM Financial, Citigroup Global Markets India, JP Morgan India and Nomura Financial Advisory and Securities (India) are acting as chief bookkeeping managers for the IPO. The company has appointed KFIN Technologies Limited as the registrar for the issue.
Biological science about the national anthem?
Founded in 2006, Anthem Biosciences is a contract research, development and manufacturing organization (CRDMO) focusing on innovation and technology. The company operates throughout the drug chain, including drug discovery, development and manufacturing. It also produces and markets based on complex fermentation-active pharmaceutical ingredients (APIs), such as probiotics, enzymes, peptides, nutritional activity, vitamin analogs and biosimilars.
